Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties
Jakub Staroń, Rafał Kurczab, Dawid Warszycki, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111857-111857
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches
Javier Vázquez, Manel López, Enric Gibert, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4723-4723
Open Access | Times Cited: 168
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress
Zhipei Sang, Keren Wang, Jianghong Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114464-114464
Closed Access | Times Cited: 90
Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands
Aida Iraji, Mahsima Khoshneviszadeh, Omidreza Firuzi, et al.
Bioorganic Chemistry (2020) Vol. 97, pp. 103649-103649
Closed Access | Times Cited: 85
Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development
Chia‐Ju Hsieh, Sam Giannakoulias, E. James Petersson, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 317-317
Open Access | Times Cited: 20
Overcoming Depression with 5-HT2A Receptor Ligands
Agata Zięba, Piotr Stępnicki, Dariusz Matosiuk, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 10-10
Open Access | Times Cited: 37
Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs
Mark J. Millan, Anne Dekeyne, Alain P. Gobert, et al.
Neuropharmacology (2020) Vol. 177, pp. 108099-108099
Open Access | Times Cited: 31
Artificial intelligence in drug development for delirium and Alzheimer’s disease
Ruixue Ai, Xianglu Xiao, Shuling Deng, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Serotonin 6 receptor blockade reduces repetitive behavior in the BTBR mouse model of autism spectrum disorder
Dionisio A. Amodeo, Brandon L. Oliver, Alma E. Pahua, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 200, pp. 173076-173076
Open Access | Times Cited: 26
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties
Vittorio Canale, Katarzyna Grychowska, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112765-112765
Open Access | Times Cited: 22
Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States
David Vanda, Vittorio Canale, Séverine Chaumont‐Dubel, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 2, pp. 1180-1196
Closed Access | Times Cited: 20
Developing a novel benzothiazole-based red-emitting probe for intravital imaging of superoxide anion
Wei Tang, Junru Liu, Qi Wang, et al.
Talanta (2023) Vol. 268, pp. 125297-125297
Closed Access | Times Cited: 8
Asymmetric Synthesis of Quaternary α‐Aryl Stereocentres in Benzofuran‐3(2H)‐Ones Using Decarboxylative Asymmetric Allylic Alkylation
Fionn McNeill, Brendan Twamley, Patrick J. Guiry
Chemistry - A European Journal (2024) Vol. 30, Iss. 46
Open Access | Times Cited: 2
Design and Synthesis of Potential Multi-Target Antidepressants: Exploration of 1-(4-(7-Azaindole)-3,6-dihydropyridin-1-yl)alkyl-3-(1H-indol-3-yl)pyrrolidine-2,5-dione Derivatives with Affinity for the Serotonin Transporter
Martyna Z. Wróbel, Andrzej Chodkowski, Agata Siwek, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11276-11276
Open Access | Times Cited: 2
Rapid Identification of Potential Drug Candidates from Multi-Million Compounds’ Repositories. Combination of 2D Similarity Search with 3D Ligand/Structure Based Methods and In Vitro Screening
Katalin Szilágyi, Beáta Flachner, István Hajdú, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5593-5593
Open Access | Times Cited: 14
Best Practices for Docking-Based Virtual Screening
Bruno J. Neves, Melina Mottin, José Teófilo Moreira-Filho, et al.
Elsevier eBooks (2021), pp. 75-98
Closed Access | Times Cited: 13
Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease
Xiaodong Dou, Qi Sun, Guofeng Xu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114508-114508
Open Access | Times Cited: 10
Aminotriazines with indole motif as novel, 5-HT7 receptor ligands with atypical binding mode
Damian Kułaga, Jolanta Jaśkowska, Grzegorz Satała, et al.
Bioorganic Chemistry (2020) Vol. 104, pp. 104254-104254
Closed Access | Times Cited: 11
Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor
Natalia Czub, Adam Pacławski, Jakub Szlęk, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1711-1711
Open Access | Times Cited: 10
In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
Tijana Bojić, Milan Senćanski, Vladimir Perović, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2626-2626
Open Access | Times Cited: 7
Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis
Syed Nasir Abbas Bukhari, Mervat Abdelaziz Elsherif, Kashaf Junaid, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 834-834
Open Access | Times Cited: 7
Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening
Agata Zięba, Damian Bartuzi, Piotr Stępnicki, et al.
ChemMedChem (2024) Vol. 19, Iss. 14
Closed Access | Times Cited: 1
Low-Basicity 5-HT6 Receptor Ligands from the Group of Cyclic Arylguanidine Derivatives and Their Antiproliferative Activity Evaluation
Przemysław Zaręba, Anna K. Drabczyk, Artur Wnorowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10287-10287
Open Access | Times Cited: 1
Identification of Novel Dopamine D2 Receptor Ligands—A Combined In Silico/In Vitro Approach
Lukas Zell, Constanze Lainer, Jakub Kollár, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4435-4435
Open Access | Times Cited: 6
Molecular insights into GPCR mechanisms for drugs of abuse
Omar B. Sánchez-Reyes, Gregory Zilberg, John D. McCorvy, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 9, pp. 105176-105176
Open Access | Times Cited: 3
Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT1A receptor and SERT
Martyna Z. Wróbel, Andrzej Chodkowski, Maciej Dawidowski, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106903-106903
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top